A systematic review revealed that patients with psoriasis have a significantly higher prevalence of onychomycosis than those without psoriasis.

Like other types of psoriasis, GPP is considered autoimmune. These conditions are not infectious diseases and cannot spread to others upon contact. There’s currently no cure for GPP, and due to ...

Patients with generalized pustular psoriasis continued to experience frequent flares that were often uncontrolled by ...

Psoriasis treatments are often similar across ... defined as hospitalization for any infectious cause up to March 2021. Among the 11,641 older adults with psoriatic disease who initiated systemic ...

Stress, extreme temperatures, and infectious illnesses can all trigger flares of scalp psoriasis. In the United States, more than 8 million people are living with psoriasis. Psoriasis frequently ...

A new cohort study published in Journal of American Medical Association suggests that biologics targeting IL-12, IL-23, and ...

Learn more about whether Jazz Pharmaceuticals plc or Johnson & Johnson is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

The Innovative Medicine focus areas include Immunology, covering medicines to treat arthritis, IBD and psoriasis; Infectious Disease, covering treatments for HIV/AIDS; Neuroscience, for treatments ...

Interim Results from FDA-Funded Study Reinforces HyBryte's Rapid Response and Strong Safety Profile PRINCETON, N.J., April 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix ...

Scratching these marks can exacerbate other skin conditions such as eczema or psoriasis ... sufferers,' says Professor Michael Marks, an infectious disease expert at the London School of Hygiene ...